Literature DB >> 16005168

Adverse effects of anabolic steroids in athletes. A constant threat.

C Maravelias1, A Dona, M Stefanidou, C Spiliopoulou.   

Abstract

Anabolic-androgenic steroids (AAS) are used as ergogenic aids by athletes and non-athletes to enhance performance by augmenting muscular development and strength. AAS administration is often associated with various adverse effects that are generally dose related. High and multi-doses of AAS used for athletic enhancement can lead to serious and irreversible organ damage. Among the most common adverse effects of AAS are some degree of reduced fertility and gynecomastia in males and masculinization in women and children. Other adverse effects include hypertension and atherosclerosis, blood clotting, jaundice, hepatic neoplasms and carcinoma, tendon damage, psychiatric and behavioral disorders. More specifically, this article reviews the reproductive, hepatic, cardiovascular, hematological, cerebrovascular, musculoskeletal, endocrine, renal, immunologic and psychologic effects. Drug-prevention counseling to athletes is highlighted and the use of anabolic steroids is must be avoided, emphasizing that sports goals may be met within the framework of honest competition, free of doping substances.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005168     DOI: 10.1016/j.toxlet.2005.06.005

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  49 in total

Review 1.  Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?

Authors:  Grace Huang; Shehzad Basaria
Journal:  Mol Cell Endocrinol       Date:  2017-07-12       Impact factor: 4.102

Review 2.  Drug-induced endocrine and metabolic disorders.

Authors:  Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Biological augmentation of rotator cuff tendon repair.

Authors:  David Kovacevic; Scott A Rodeo
Journal:  Clin Orthop Relat Res       Date:  2008-02-10       Impact factor: 4.176

Review 4.  Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review.

Authors:  John Nasr; Jawad Ahmad
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

5.  Computational Assessment of Pharmacokinetics and Biological Effects of Some Anabolic and Androgen Steroids.

Authors:  Marin Roman; Diana Larisa Roman; Vasile Ostafe; Alecu Ciorsac; Adriana Isvoran
Journal:  Pharm Res       Date:  2018-02-05       Impact factor: 4.200

6.  Can we consider religiousness as a protective factor against doping behavior in sport?

Authors:  Jelena Rodek; Damir Sekulic; Emir Pasalic
Journal:  J Relig Health       Date:  2008-09-26

7.  Matrix metallopeptidase 2 activity in tendon regions: effects of mechanical loading exercise associated to anabolic-androgenic steroids.

Authors:  Rita C Marqueti; Jonato Prestes; Milena Paschoal; Oscar H P Ramos; Sérgio E A Perez; Hernandes F Carvalho; Heloisa S Selistre-de-Araujo
Journal:  Eur J Appl Physiol       Date:  2008-09-23       Impact factor: 3.078

Review 8.  Skin conditions of baseball, cricket, and softball players.

Authors:  Joshua A Farhadian; Brook E Tlougan; Brian B Adams; Jonathan S Leventhal; Miguel R Sanchez
Journal:  Sports Med       Date:  2013-07       Impact factor: 11.136

9.  Effects of different doses of nandrolone decanoate on estrous cycle and ovarian tissue of rats after treatment and recovery periods.

Authors:  Vinícius Augusto Simão; Larissa Berloffa Belardin; Gabriel Adan Araújo Leite; Luiz Gustavo de Almeida Chuffa; Isabel Cristina Cherici Camargo
Journal:  Int J Exp Pathol       Date:  2015-11-17       Impact factor: 1.925

Review 10.  The effects of endogenous and exogenous androgens on cardiovascular disease risk factors and progression.

Authors:  Panagiota Manolakou; Roxani Angelopoulou; Chris Bakoyiannis; Elias Bastounis
Journal:  Reprod Biol Endocrinol       Date:  2009-05-12       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.